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Mesoporous Silica Materials for Controlled Delivery based on 
Enzymes   
Antoni Llopis-Lorente,a,b,† Beatriz Lozano-Torres,a,b,† Andrea Bernardos,a,b Ramón Martínez-
Máñez,*a,b,c and Félix Sancenóna,b,c 
This review summarises examples of capped mesopous silica materials for controlled delivery that uses enzymes as 
external triggers or functional components of the gating ensemble. 
 
1. Introduction 
The functionalisation of inorganic materials with molecular or 
supramolecular assemblies has recently led to the preparation of 
hybrid materials, within the nanoscale range in many cases, with 
advanced functionalities.1,2 In fact grafting organic (bio)molecules 
or supramolecules onto selected inorganic solids (with different 
natures, sizes and shapes) has promoted the development of smart 
nanodevices with applications in several scientific fields.3-7 Within 
the realm of functional nanodevices, one appealing concept is 
related with the design of gated materials. These systems are 
constructed for the purpose of finely tuning the movement of 
(bio)chemical species from the voids of porous supports to a 
solution in response to an external stimulus.8 These nanodevices 
are generally composed of two subunits: (i) a porous inorganic 
support, on which a cargo is entrapped; and (ii) selected molecular 
and/or supramolecular entities, grafted onto the external surface, 
which control mass transport from the pores to the solution. In this 
field, one of the most widely used inorganic supports has been 
mesoporous silica nanoparticles,9-12 whereas the gating 
mechanisms takes advantage of electrostatic or supramolecular 
interactions, the rupture/formation of covalent bonds, or changes 
in the physical properties of molecules or macromolecules.13-21 
Gated materials have found high potential applications in the field 
of controlled release protocols and in the development of new 
sensing/recognition paradigms.22 
One of the most appealing triggers used to develop gated 
materials are enzymes.8,22 For this purpose, the most commonly 
used enzymes are oxidoreductases, transferases, hydrolases, 
lipases, nucleases, phosphatases, glycosidases, lyases, isomerases 
and ligases. The use of enzymes for uncapping gated materials is 
appealing. In fact the use of tailor-made specific (bio)organic 
derivatives and selected enzymes is envisioned to have a huge 
potential, which may provide the design of advanced gated devices 
for delivery at will of drugs and (bio)molecules in realistic biological 
environments with high selectivity. Moreover, enzymes have also 
been used as bulky capping units.  
This review intends to comprehensively analyse published 
papers that have used enzymes (Table 1) in combination with 
porous materials to design gated supports for different 
applications. The review is divided into two main sections that take 
into account the role played by the enzyme, namely (i) enzymes as 
functional components in the gating ensemble and (ii) enzymes as 


















Figure 1. Schematic representation of molecular gates, for on-
command controlled release, based on using enzymes. A) Enzymes 
are used as functional components in the gating ensemble and 
materials are uncapped in the presence of a certain target stimulus. 
B) Enzymes are used as a trigger to uncap pores via, e.g., hydrolysis 
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Table 1. Summary of the enzymes employed in the design of the 




Acid phosphatase 67 
α-Amylase 83 
Carbonic anhydrase (CA) 25 
Caspase 58 
Catalase (CAT) 28 
Cathepsin B 44-46 
Cellulose glycosidase 85 
α-Chymotrypsin A (CTRA) 33 
DNAses 68-70 
Esterase 29, 30, 59-66, 86 
β-ᴅ-Galactosidase enzyme 71, 74 
Glucose oxidase (GOx) 26-28, 30, 91 
Glutathione S-transferase (GST) 24 
Horseradish peroxidase (HRP) 91 









Pancreatin 56, 72, 73, 84 
Protease 36- 43, 54 




Urease 23, 32, 55 
 
2. Enzymes as functional components 
In this section, enzymes are used as components of the gating 
ensemble and their function in most cases is to cap the pores of the 
inorganic matrix. The opening and subsequent delivery of the 
entrapped cargo are induced using different external stimuli; e.g., 
presence of certain molecules or by changes in the pH of the 
environment. 
2.1. pH triggered release 
Lee and co-workers prepared pH-responsive mesoporous silica 
nanoparticles (MSNs) capped with urease and a calcium phosphate 
shell.23 First, MSNs were functionalised with aminopropyl moieties, 
which were further reacted with glutaraldehyde to yield aldehyde 
groups on the external silica surface. Afterwards, the authors linked 
enzyme urease to the aldehyde groups through the formation of 
imine bonds. Doxorubicin (DOX) was loaded into pores and the 
system was closed by the enzyme-mediated formation of a calcium 
phosphate coating using hydroxyapatite and urea. At pH 7.4, the 
system remained capped, but DOX delivery was remarkable at pH 
4.5 due to the dissolution of the calcium phosphate layer under 
acidic conditions (see Figure 2). The DOX-loaded nanoparticles were 
tested in MCF-7 cancer cells and induced cell death was observed 
due to the gradual release of DOX at the lysosomal pH. 
 
Figure 2. MSNs loaded with DOX, functionalised with urease and 
capped with a calcium phosphate shell. DOX was released at an 
acidic pH. 
Chen and co-workers developed MSNs capped with glutathione 
S-transferase (GST) capable of cargo delivery using pH changes and 
glutathione as triggers.24 The external surface of MSNs was 
functionalised with (3-aminopropyl)triethoxysilane (APTES), 
followed by the encapsulation of rhodamine 6G (Rh 6G) or DOX 
inside the inorganic scaffold pores. Finally, the system was capped 
by GST, which interacted electrostatically with the amino groups of 
the surface. The payload delivery was triggered proportionally as pH 
lowered from 0% at pH 7.4 to 98% at pH 3.9. The authors also found 
that glutathione induced a change in the enzyme conformation with 
subsequent cargo release. These nanoparticles were tested in yeast 
cells, and cell death was induced when treated simultaneously with 
DOX-loaded nanoparticles and glutathione. 
Bein and co-workers prepared MSNs loaded with fluorescein 
and capped with enzyme carbonic anhydrase (CA), which was 
bound reversibly through its active centre to the aryl sulphonamide 
groups grafted onto the surface of nanoparticles.25 The CA-capped 
MSNs showed a negligible release at pH 7.4, whereas marked 
fluorescein delivery was observed at an acidic (5.5) pH. The release 
mechanism was based on protonation of sulphonamide in an acidic 
medium, which caused enzyme detachment and the uncapping of 
pores. Additionally, the enzyme was modified with an unnatural 
amino acid that contained a norborene moiety, which allowed for 
the additional site-specific attachment of tetrazine-modified 
targeting ligands, such as folic acid and anandamide. The targeting 
capability of the folate-functionalized system was tested on KB 
cancer cells, whereas the anandamide-functionalized system was 
tested on neural stem cells and A431 cells. Furthermore, the release 
in HeLa cells from CA-capped nanoparticles loaded with DAPI was 
investigated. It suggested that delivery was due to acidification 
throughout the endosomal pathway to late endosomes. Finally, the 
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prepared and tested in HeLa cells. These nanoparticles produced an 
intracellular AmD release and caused remarkable cell death. 
2.2. Glucose triggered release 
Glucose-responsive MSNs capped with glucose oxidase (GOx) 
were developed by Lu and co-workers.26 The external silica surface 
of MSNs was functionalised with prop-2-yn-1-yl(3-
(triethoxysilyl)propyl) carbamate. Then inhibitor ᴅ-(+)-glucosamine 
was grafted through a click chemistry reaction. Rhodamine B (Rh B) 
was loaded into pores and GOx was used as caps via the formation 
of a complex with the grafted inhibitor. In the presence of glucose, 
GOx was displaced from the nanoparticles and a proportional dye 
release was observed. Other tested monosaccharides (i.e., fructose, 
mannose and galactose) did not induce the payload release.  
Another glucose-responsive system, which also used GOx, was 
developed by Villalonga, Martínez-Máñez and co-workers.27a In this 
case, MSNs were loaded with Ru(bipy)32+, functionalised with 
benzimidazole groups and capped with GOx that had been 
previously modified with β-cyclodextrin (β-CD). The CDs groups in 
CD-GOx formed an inclusion complex with the propylbenzymidazole 
stalks on the surface of nanoparticles by capping pores. In the 
presence of glucose, the GOx catalysed oxidation of glucose to 
gluconic acid, which induced the protonation of the benzimidazole 
group, resulted in CD-GOx displacement and clear cargo delivery. 
The systems were proposed as a potential glucose probe. The 
system gave not only a linear response to glucose within the 1x10-2-
1x10-4 mol L-1 range, but also and a LOD of 1.5x10-4 mol L-1. Other 
saccharides (i.e. mannose, fructose, galactose, maltose and 
saccharose) produced no delivery. The same authors utilised this 
gating system on pore-expanded MSNs for delivery of insulin in 
simulated blood plasma.27b 
An insulin delivery system responsive to glucose was described 
by Shi and co-workers, which used enzyme GOx.28 MSNs with a pore 
size of ca. 12 nm were synthesised and pores were loaded with 
insulin. Then the loaded nanoparticles were coated with 
poly(ethyleneimine) through electrostatic interactions with silanol 
moieties on the external surface. The amino moieties of the 
poly(ethyleneimine) layer were reacted with glutaraldehyde. Then 
enzymes GOx and catalase (CAT) were immobilised through the 
formation of imine bonds. Addition of glucose led to its oxidation to 
gluconic acid by GOx, a drop in the pH of the microenvironment and 
a subsequent increase in coating multilayer permeability, which 
induced insulin release. The CAT enzyme was used to eliminate the 
hydrogen peroxide produced in the GOx-mediated reaction. 
Villalonga, Martínez-Máñez and co-workers prepared MSNs 
loaded with Ru(bipy)32+, functionalised on the outer surface with 
phenyl boronic acid moieties, and capped with lactose-modified 
esterase.29 The neoglycoenzyme was linked to the surface by the 
formation of cyclic boronic acid esters with (i) the naturally-
occurring glycosylation chains of the esterase and (ii) the 
synthetically-introduced lactose residues in the enzyme. The 
delivery system exhibited a two-step controlled cargo release 
triggered by glucose and ethyl butyrate. Presence of glucose 
resulted in the release of ca. half the cargo by the disruption of 
lactose-boronic acid linkages due to glucose competition. Addition 
of ethyl butyrate, which was transformed into ethanol and butyric 
acid by esterase, induced a subsequent drop in pH and the acid-
mediated hydrolysis of boronic acid esters, which finally induced 
complete enzyme detachment and a full payload delivery. 
Furthermore, the authors loaded nanoparticles with DOX, and the 
nanodevice was used to release DOX in HeLa cells in the presence of 
a mixture of D-glucose and ethyl butyrate. 
A more complex Janus-type nanodevice was described also later 
by Villalonga, Martínez-Máñez and co-workers.30 The support 
consisted on Janus-type nanoparticles with gold and mesoporous 
silica faces on opposite sides. The mesoporous silica face allowed 
for cargo loading and functionalization whereas the Au face allowed 
the immobilization of certain enzymes. In this case, the silica matrix 
was loaded with Ru(bipy)32+ and capped by the formation of 
inclusion complexes between grafted benzimidazole moieties and 
β-CDs. The Au side was also functionalized with two enzymes (GOx 
and esterase). Either ᴅ-glucose or ethyl butyrate was converted, by 
the enzymatic system, into gluconic acid or butyric acid to induce a 
local drop in pH, the protonation of the benzimidazole groups, the 
rupture of the benzimidazole-β-CD interaction and a payload 
delivery. The same authors prepared another nanodevice that 
incorporated enzyme urease together with GOx and esterase. In 
this three-enzyme nanodevice, the payload delivery from the silica 
matrix was triggered by glucose and was stopped by adding urea. 
This stop in cargo delivery was due to the neutralisation of an acidic 
medium by ammonia produced through the uresase-catalysed 
reaction. The GOx- and esterase-containing Janus nanoparticles 
were loaded with DOX and were successfully tested for DOX 
delivery in HeLa cells upon exposure to glucose, ethyl butyrate, or a 
mixture of both compounds. 
2.3. Other stimuli 
Slowing, Trewyn and co-workers used gold nanoparticles 
(AuNPs) and luciferase as caps to prepare gated MSNs responsive to 
reducing agents.31 The silica surface was first functionalised with 
thiol moieties and later with 
[methoxy(polyethylenoxy)propyl]trimethoxysilane to obtain a 
PEGylated surface. Thiol moieties were further linked to 3-
(propyldisulfanyl)ethylamine by the formation of disulfide bonds. 
Nanoparticles were loaded with luciferin (luciferase substrate) and 
capped with AuNPs functionalised with carboxylic-terminated 
poly(ethylene glycol) (PEG) through the formation of amide bonds 
with amino groups on the surface of MSNs. Finally, enzyme 
luciferase was physisorbed on the PEGylated external surface of 
capped MSNs by electrostatic interactions. In the presence of DTT, 
disulphide bonds were broken and a luminescent response was 
observed due to the simultaneous release of substrate luciferin 
from pores and enzyme luciferase from the surface. The designed 
system was tested in HeLa cells, which confirmed luciferin delivery 
due to the intracellular reducing environment.  
Villalonga and co-workers reported a new delivery system 
based on Janus-type nanoparticles with opposing Au and 
mesoporous silica faces in which the enzyme urease mediated the 
conversion of urea to ammonia and the consequent cargo 
delivery.32 In particular, the gold face was functionalised with a 
thiol-modified urease enzyme. Previously, the mesoporous silica 
face was loaded with Ru(bipy)32+ and functionalised on the external 
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surface with 3-(2-aminoethylamino)propyl trimethoxysilane than 
acted as a molecular gate. The gate was closed at pH 5.0 due to the 
protonation of polyamines. In the presence of urea, a clear delivery 
of the entrapped ruthenium complex took place. The opening 
mechanism was based on transforming urea into CO2 and NH3 by 
urease, which induced a rise in pH and the subsequent 
deprotonation of polyamines.  
Wang and co-workers recently described MSNs loaded with Rh 
6G or DOX, and capped with enzyme α-chymotrypsin A (CTRA), 
which were capable of cargo release in the presence of CTRA 
inhibitor phenylmethanesulfonyl fluoride (PMSF).33 To prepare the 
final device, MSNs were functionalised with APTES, loaded with the 
corresponding cargo and finally capped with CTRA through 
electrostatic interactions between the negatively charged enzyme 
and the positively charged protonated amino groups onto the silica 
surface. Upon PMSF addition or pH acidification, CTRA underwent a 
conformational change that induced its detachment from the 
surface of nanoparticles, which resulted in cargo release. The 
authors also found that the nanoparticles loaded with DOX were 
capable of cargo delivery in yeast cells upon the addition of PMSF. 
Fluorophore propidium iodide, which is cell-membrane 
impermeable, was also used as a cargo to demonstrate successful 
intracellular delivery. 
Using enzyme-inhibitor interactions, Martínez-Máñez and co-
workers have very recently prepared acetylcholinesterase-capped 
nanoparticles capable of delivering Rh B selectively in the presence 
of nerve agent simulant diisopropyl fluorophosphate (DFP).34 MSNs 
were loaded with Rh B and the external surface was functionalised 
with a pyridostigmine derivative. Pyridostigmine is a well-known 
acetylcholinesterase reversible inhibitor. Finally, pores were capped 
by the interaction between the acetylcholinesterase active-site and 
the anchored pyridostigmine derivative (see Figure 3). DFP is a 
stronger inhibitor than pyridostigmine and was able to displace 
acetylcholinesterase from the silica surface, which resulted in clear 
cargo delivery. The detection system responded selectively to DFP 
and better than other nerve agent simulants and 
organophosphorus derivatives. 
 
Figure 3. MSNs functionalised with a pyridostigmine derivative and 
capped with acetylcholinesterase enzyme. Pore opening and Rh B 
release was induced by presence of DFP. 
pH-responsive capped MSNs were prepared by Yang and co-
workers. MSNs were modified with poly(2-dimethylaminoethyl 
methacrylate) brushes by peroxidase mimetic catalytic atom 
transfer radical polymerization (ATRP) and loaded with rhodamine 
6G.35 PBS suspensions of the nanoparticles at pH 7.4 showed a 
moderate rhodamine 6G release. However, a marked dye delivery 
was observed upon lowering the solution pH to 2.0. The release was 
ascribed to electrostatic repulsions between positively-charged 
polymer chains that adopted an extended conformation with 
subsequent pore opening. 
3. Enzymes as triggers 
This section details gated MSNs capable of cargo release in the 
presence of enzymes. This approach offers an enormous potential 
by taking into account the vast number of gating ensembles that 
can be envisioned and can be hydrolysed/ modified by the presence 
of one enzyme or by a combination of enzymes. The examples in 
the next sections were classified after taking into account the type 
of enzyme used as a trigger. 
3.1. Proteases and hydrolysis of amide groups 
Avidin-biotin capped MSNs, for protease-responsive controlled 
releases, were prepared by Bein and co-workers.36 MSNs were 
functionalised with propanethiol moieties and loaded with 
fluorescein.  Then thiol groups were reacted with biotin-maleimide 
to yield a biotinylated surface. Pore closure was achieved upon 
avidin addition due to the formation of avidin-biotin complexes 
onto the surface of MSNs. Pore opening was achieved by adding 
protease trypsin. This protease hydrolysed avidin with the 
subsequent release of the entrapped fluorescein.  
Another example of enzyme-responsive systems based on 
peptide-modified mesoporous silica was described by Heise et al.37 
In this work, silica microparticles functionalised with amines were 
loaded with fluorescein isothiocyanate (FITC)-functionalised dextran 
(4 kDa). A bioactive peptide shell, which consisted of Fmoc-
terminated glutamic acid and enzyme-cleavable Ala-Ala bonds, was 
directly coupled to silica particles by stepwise Fmoc solid-phase 
peptide synthesis. The specific enzymatic hydrolysis of peptide 
linkers removed the bulky Fmoc groups and allowed the selective 
release of previously entrapped guest molecules.  
Polymer-coated MSNs loaded with DOX and responsive to 
proteases were prepared by Bathia and co-workers.38 Nanoparticles 
were first modified with N-(3-aminopropyl) methacrylamide 
hydrochloride (APMA), which bound MSNs electrostatically, and 
were loaded with DOX. Moreover, poly(ethylene glycol) diacrylate 
(PEGDA) was functionalised either with CGPQGIWGQGCR (highly 
degradable by MMPs) or CGPQGPAGQGCR (low degradable by 
MMPs) bis-cysteine peptides by a Michael addition reaction. Finally, 
a radical co-polymerisation between the acrylamide group of APMA 
and the terminal acrylate group of PEGDA-peptide yielded the 
coated material. Nanoparticles were incubated with 3T3-J2 
fibroblasts and induced apoptosis was achieved due to DOX release 
as a result of the polymeric coating hydrolysis.  
Deflavined GOx was used as a cap to prepare protease-triggered 
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with APTES and further reacted with glutaraldehyde. Then cofactor 
flavin adenine dinucleotide (FAD) was reacted with the aldehyde 
groups on the surface of MSNs by reductive amination. 
Nanoparticles were loaded with Rh B and capped with enzyme 
deflavined GOx, which was immobilised through the specific 
interaction with the cofactor. In the presence of protease K, GOx 
was digested with the subsequent Rh B delivery. The authors also 
demonstrated that no release of Rh B took place in the presence of 
protease K inhibitors, such as phenylmethyl-sulfonylfluoride and 
Hg2+. 
Martínez-Máñez and co-workers prepared MSNs loaded with 
DOX and capped with a cyclic peptide to obtain a nanomaterial to 
target B-cell non-Hodking’s lymphoma (B-NHL), the most frequent 
malignant lymphoid neoplasm.40 MSNs were loaded with DOX and 
the external surface of nanoparticles was decorated with alkyne 
moieties using a propargylamine derivative. Finally, pores were 
capped with an azide-functionalised T22 peptide analogue (that 
recognises the CXCR4 receptor in B-NHL cells) using a “click” 
chemistry reaction. Capped nanoparticles exhibited remarkable 
DOX release in the presence of proteases, whereas poor cargo 
delivery was observed when they were absent. Experiments in B-
NHL cells allowed to assess the targeting effect of capped 
nanoparticles on CXCR4 receptor by flow cytometry. Finally, 
cytotoxic studies revealed a marked reduction in cell viability in B-
NHL cells incubated with DOX-loaded nanoparticles.  
A protease-responsive system loaded with two cytotoxic agents 
was reported by Van Rijt and co-workers.41 The system consisted in 
MSNs loaded with non-toxic doss of cisplatin and bortezomib (Bz), 
functionalised with a specific biotin-heptapeptide (RSWMGLP) 
linker, which can be cleaved by MMP-9 and capped with avidin. The 
authors prepared MSNs that contained amino groups on the silica 
surface. Then the peptide linked to biotin was anchored to MSNs by 
the formation of amide bonds between the peptide carboxylic 
group and the amide moieties on the silica surface. Afterwards, 
nanoparticles were loaded with cisplatin and Bz, and were capped 
with avidin given its strong affinity to biotin. In the presence of 
MMP-9, the heptapeptide sequence was cleaved and nanoparticles 
exhibited remarkable cargo release. For the in vitro studies, A549 
and H1299 (lung cancer) cells were transfected to overexpress 
MMP-9 and were treated with the nanoparticles. The authors 
demonstrated that a larger number of cells underwent apoptosis 
when treated with the solid loaded with both cytotoxics than when 
treated with the nanoparticles loaded with only one compound. 
Moreover, the therapeutic effect of nanoparticles on Kras mutant 
mice and the ex vivo tissue cultures from healthy and tumoural 
human lungs were also studied. 
Martínez-Máñez and co-workers prepared pronase-responsive 
MSNs loaded with Rh B or DOX, and functionalised with polymer 
polyglutamic-acid, which acted as a capping unit.42 In this case, 
polyglutamic-acid was anchored to the surface of MSNs previously 
modified with APTES thanks to the formation of amide bonds. In the 
presence of pronase, peptide bonds were cleaved and remarkable 
cargo release was observed. Capped nanoparticles were 
successfully tested in SK-BR-3 breast cancer cells. 
In another work, the same research group also developed 
peptide-capped MSNs capable of releasing an entrapped cargo in 
the presence of protease enzymes.43 For this purpose, MSNs were 
loaded with Ru(bipy)32+ dye and the external surface was 
functionalised with azidopropyl moieties. Then pores were capped 
with 4-pentynoic acid-functionalised H-GGD EVD GGD EVD GGD 
EVD-OH peptide through a click chemistry reaction. The release of 
the entrapped complex was hindered in the absence of protease. 
However, when proteolytic enzymes from Streptomyces griseus 
(PESG) were present in the suspension, a marked payload release 
took place due to peptide hydrolysis (see Figure 4A). 
The same authors also designed cathepsin B-responsive capped 
MSNs.44 For this purpose, safranin O or DOX was loaded into the 
pores of MSNs and the external surface was functionalised with 3-
(azidopropyl) triethoxysilane. A click reaction between the 
azidopropyl groups on the surface and an alkynyl-derivatised 
peptide (alkynyl-GIV RAK EAE GIV RAK-OH) was used to prepare the 
final capped nanoparticles (see Figure 4B). Studies have 
demonstrated that cargo release was achieved only in the presence 
of lysosomal extracts that contained cathepsin B. Moreover, the 
capped nanoparticles loaded with safranin O or cytotoxic drug DOX 
were also tested in HeLa cancer cells and primary culture cells of 
mouse embryonic fibroblasts (with cathepsin B overexpression). 
The authors found that safranin release in these cells was achieved 
through the action of cathepsin B. In fact preincubating cells with a 
cathepsin B-inhibitor remarkably reduced the safranin O-associated 
signal inside cells. Cell death was clearly observed when using the 
gated nanoparticles loaded with DOX. Also in this case, 
preincubating cell cultures with a cathepsin B inhibitor diminished 
cell death.  
 
Figure 4. Controlled cargo release induced by peptidase or 
cathepsin B from MSNs capped with specific peptide sequences. 
Li and co-workers also described cathepsin B-responsive capped 
nanodevices45 using quantum dots (QDs) coated with a mesoporous 
silica shell. This silica shell was loaded with DOX and the surface 
was functionalised with aminopropyl moieties that were further 
reacted with a maleimide-PEG2-succinimidyl ester cross-linker. 
Afterwards, peptide CRRRQRRKKR-PGFK-EEEEEE was anchored to 
the silica surface by the formation of amide bond between the 
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contained the PGFK fragment, which is selectively hydrolysed by 
cathepsin B protease. The authors noted negligible DOX release 
when capped nanoparticles were suspended in PBS at pH 5.5. 
However, presence of cathepsin B induced remarkable DOX 
delivery. Further studies carried out with the peptide-capped 
nanoparticles showed remarkable DOX delivery in A549 cells (with 
high levels of cathepsin B) and negligible delivery in NIH 3T3 cells 
(with no cathepsin B activity). Moreover, A2780 (normal) and 
A2780Adr (DOX-resistant cells) were treated with either free DOX 
or nanoparticles. Free DOX could only reach the nucleus of A2780, 
whereas DOX was released in the nucleus of both cell lines when 
nanoparticles were used. 
Feng He and co-workers reported MSNs loaded with DOX and 
capped with α-CDs, and an oligopeptide that was hydrolysed by 
enzyme cathepsin B.46 The mesoporous support was functionalised 
with α-(2-aminoethyl)-aminopropyl trimethoxysilane, and the 
primary amino groups were further reacted with propargyl bromide 
to yield MSNs functionalised with stalks that contained alkyne and 
secondary amino moieties. In a second step, the pores of alkyne-
functionalised MSNs were loaded with DOX and an inclusion 
complex between the secondary amino groups in the stalk, and α-
CD was formed. Finally, a click reaction between alkyne moieties 
and a previously prepared azido-containing peptide GFLGR7RGDS 
prevented the dethreading of α-CDs. The PBS suspensions of 
capped nanoparticles (at pH 7.4 or 5.0) showed less than 10% DOX 
release (after 60 h) in the absence of cathepsin B. However in the 
presence of enzyme, a marked payload delivery was observed (ca. 
80% at pH 5 and 70% at pH 7.4). Nanoparticles were more quickly 
internalised in HeLa (cancer) than COS7 (normal) cells, and the 
cytotoxic effect was higher in Hela cells. 
Raichur and co-workers developed a trypsin-driven drug 
delivery system.47 For this purpose, MSNs were loaded with 
diclofenac and the external surface of nanoparticles was 
functionalised with aminopropyl moieties. In a second step, 
protamine was grafted onto the external surface through the 
formation of imine bonds, using glutaraldehyde as a cross-linker. 
Minimal cargo release was observed in the absence of trypsin. 
However, selective diclofenac delivery was observed in the 
presence of the enzyme. These authors also evaluated the ability of 
capped MSNs to deliver anticancer drugs to colorectal cancer cells. 
For this purpose, MSNs loaded with the antineoplasic drug 
curcumin, and capped with protamine, were prepared. COLO205 
cells were able to internalise protamine-capped nanoparticles and, 
as a result of the hydrolysis of the cap, intense curcumin 
fluorescence was observed inside cells. However, negligible 
curcumin fluorescence was observed when cells were incubated 
with curcumin suspended in water. Besides, cytotoxic studies also 
demonstrated that curcumin-loaded capped MSNs significantly 
enhanced anticancer activity compared with the free drug.  
MSNs loaded with DOX and capable of cargo delivery in the 
presence of metalloproteinase (MMP) were developed by Zhang 
and co-workers.48 As a first step, mercaptopropyl moieties were 
anchored onto MSNs and the thiol group was further reacted with 
S-(2-aminoethylthio)-2-thiopyridine, which resulted in the 
formation of disulphide bonds. DOX was loaded into mesopores and 
the amino moieties grafted onto the external surface were 
functionalised with propargyl bromide. Then a “click” chemistry 
reaction between the external alkyne moieties and mono-6-azido-
β-CD was run. Afterwards, the N3-GPLGVRGRGDK-adamantane 
peptide was used to form inclusion complexes with the β-CD onto 
the nanoparticle surface. In the last step, the azide group of the 
peptide was reacted with alkyne-modified poly(aspartic acid) 
polymer to yield the final material. Fragment PLGVR can be 
recognised and triggered by MMP. The controlled release behaviour 
of the prepared solid was evaluated in vitro using the SCC-7 
(squamous carcinoma) and HT-29 (human colon cancer) cell lines, 
which overexpress MMP, and with non-cancerous cells 293T 
(human embryonic kidney) as controls. These studies demonstrated 
that the capped MSNs loaded with DOX were internalised by cells. 
The hydrolysis of the PLGVR fragment by MMPs in tumoural cells, 
led to DOX being delivered and induced SCC-7 and HT-29 cell 
apoptosis. 
MMP-9 enzyme-responsive nanoparticles were prepared by 
Wang and co-workers.49 The pores of MSNs were loaded with DOX 
and the external surface was functionalised with aminopropyl 
moieties. In a second step, external amino groups were reacted 
with glutaraldehyde and pores were capped upon gelatine addition. 
Aqueous suspensions of the capped nanoparticles at pH 7.4 showed 
negligible drug release, whereas moderate delivery was noted in 
the presence of MMP-9. Release of DOX was ascribed to the 
hydrolysis of gelatine coating by enzyme MMP-9. The intracellular 
uptake and cytotoxicity of the gelatine-capped nanoparticles were 
studied using the LO2 (with no MMP-9 activity) and cancer HT-29 
(with MMP-9 activity) cell lines, which evidenced an efficient 
response only in the cancer HT-29 cells. In vivo studies in xenograft 
mice models (HT-29) showed delayed tumour growth upon the 
injection of DOX-loaded gelatin-capped nanoparticles. 
Cai and co-workers synthesised peptide-capped MSNs 
responsive to MMPs.50 MSNs were functionalised with APTES, and 
then the carboxylic groups of a modified peptide sequence (Fmoc-
NH(CH2)5CO-PLGLARR-(CH2)5COOH) were attached to the amino 
groups on the silica surface through the formation of amide bonds. 
Nanoparticles were loaded with DOX and the peptide was linked by 
its free end to bovine serum albumin (BSA) to cap pores. Finally, 
lactobionic acid (LA) was covalently attached to BSA in order to 
achieve better cell targeting and to improve endocytosis efficiency; 
58% of DOX was released in the presence of MMP-13 after 8 h, 
while only 18% was delivered when the enzyme was absent. The 
authors observed that nanoparticles had a cytotoxic effect on 
HepG2 cells. In vivo studies were performed in mice injected with 
HepG2 cells to obtain the tumour model. Reduced tumour weight 
and volume were observed in the mice treated with nanoparticles.  
Following this idea, the same group designed MSNs 
functionalised with an MMP-2-sensitive peptide and capped with 
phenylboronic acid (PBA)-conjugated human serum albumin 
(HAS).51 In order to prepare the final material, MSNs were modified 
with 3-(triethoxysilyl)propyl succinic anhydride, which was 
hydrolysed to yield MSNs functionalised with carboxylic groups. 
MSNs were further reacted with a specific polypeptide (NH2-
GR9PVGLIGG-COOH) and loaded with DOX. Finally, nanoparticles 
were capped by a reaction between the amino groups of the 
previously obtained PBA-HAS complex and the carboxylic groups at 
the end of the polypeptide on the silica surface. The delivery studies 
showed that DOX release was negligible when there was no enzyme 
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in the medium, whereas remarkable delivery was observed in the 
presence of MMP-2 due to the hydrolysis of the PVGLIG sequence 
in the peptide. The authors used three different cell lines (HepG2, L-
7702 and Raw264.7) to carry out in vitro studies, and they centred 
the cytotoxicity assays on HepG2 to accomplish good inhibition of 
cell growth when the DOX-loaded MSNs were in cultured media. 
For the in vivo studies, mice were injected with different treatments 
(blank, free DOX or nanoparticles). For the HepG2 xenografted mice 
treated with the DOX-loaded MSNs, the volume and weight of 
tumours lowered and side-effects diminish compared to free DOX. 
Zhang and co-workers prepared a therasnostic system based on 
CPT-loaded peptide-capped MSNs responsive to MMP-2.52 The 
authors synthesised a specific peptide (GPLGVRGKK-N3) with a 
terminal azide group. This peptide was functionalised with 
quencher 4,4-dimetylamino-azobenzene-4’-carboxylic acid (Dabcyl), 
which was coupled to the primary amine of lysine and with dye 
carboxytetramethylrhodamine hydrochloride (TAMRA), which was 
coupled to the N-terminal of the peptide. MSNs were functionalised 
with alkyne groups and loaded with CPT. Then the peptide 
derivative and an additional tumour targeting peptide (RGDFK-N3) 
were attached by a “click” reaction. In the absence of MMP-2, the 
system was capped and the proximity between TAMRA and Dabcyl 
resulted in no fluorescence. In the presence of MMP-2, the capping 
peptide was cleaved, TAMRA fluorescence was activated (due to 
the separation from the quencher) and CPT was released. The 
therasnostic system was tested in SCC-7 cancer cells with high 
MMP-2 expression and in COS7 normal cells that did not 
overexpress this enzyme. It was demonstrated that CPT was 
selectively released in cancer cells and that endocytosis was 
enhanced due to the interactions between the targeting peptide 
and cell receptors. 
Martínez-Máñez and co-workers used ε-poly-ʟ-lysine as caps to 
prepare amidase-responsive nanoparticles.53 MSNs were loaded 
with Ru(bipy)32+ and the external surface was functionalised with ε-
poly-ʟ-lysine by two different strategies; i.e. (i) the random 
formation of urea bonds between isocyanate-functionalised MSNs 
and the amino groups located on the ε-poly-ʟ-lysine backbone and 
(ii) the reaction between an alkyne derivative of ε-poly-ʟ-lysine with 
azidopropyl-functionalised MSNs. In both cases, selective cargo 
delivery in the presence of amidase was observed due to the amide 
bond hydrolysis of the peptide. Cell internalisation and Ru(bipy)32+ 
delivery studies were carried out with both gated materials in HeLa 
cells. Furthermore, HeLa cell treatment with the ε-poly-ʟ-lysine-
capped nanoparticles loaded with cytotoxic drug camptothecin 
(CPT) efficiently reduced cell viability.  
Amidase and pronase responsive MSNs were developed by the 
research group of Martínez-Máñez.54 MSNs were loaded with 
safranin O and treated with excess N-(3-
triethoxysilylpropyl)gluconamide to obtain a dense polymeric 
gluconamide layer to coat nanoparticles. In the presence of 
amidase or pronase, gluconamide moieties were hydrolysed with 
subsequent pore uncapping and safranin O release. The authors 
also found that nanoparticles successfully delivered the cytotoxic 
drug CPT in the HeLa and MCF-7 cancer cells due to the degradation 
of the molecular gate by lysosomal enzymes. The same authors 
reported MSNs capped with a bulky molecule that contained amide 
and urea moieties. The mesoporous support was loaded with 
Ru(bipy)32+ and a molecule that contained amide and urea bonds at 
predefined positions was anchored to the external surface as a 
cap.55 In the presence of amidase, 40% of the dye was released due 
to the hydrolysis of the amide bonds at the far end of the capping 
molecule. In the presence of urease, the hydrolysis of the urea bond 
near the silica surface resulted in a more drastic uncapping of pores 
and 80% of the cargo was delivered. A synergistic effect was 
observed in the presence of both enzymes, which resulted in fast 
complete cargo delivery. Furthermore, these nanoparticles were 
internalised by HeLa and MCF-7 cell lines, and they successfully 
delivered their cargo in the lysosomal compartment. The capped 
nanoparticles loaded with CPT were also prepared and were able to 
induce HeLa cell death.  
A pancreatin-responsive material loaded with pro-drug 
sulfasalazine (SZ) was reported by Yu and co-workers.56 Firstly, 
MCM-48-type nanoparticles were functionalised with APTES and 
then loaded with SZ. In order to cap the pores of nanoparticles, 
succinylated soya protein isolate (SSPI) was anchored to the 
external surface by the formation of amide bonds. A payload 
release was studied under different gastrointestinal simulated 
conditions: (i) stomach (pH 1.2, in the presence of pepsin, 2 h), 
duodenum (pH 5.5, 1 h) and the small intestine (pH 7.4 in the 
presence of pancreatin, > 8 h). Whereas no release was observed in 
the simulated stomach and duodenum, prodrug SZ was released in 
the simulated small intestine due to the hydrolysis of the SSPI cap 
induced by pancreatin. The authors also demonstrated that in the 
presence of azo-reductase producing bacteria, which are present in 
the lower part of the small intestine and colon, SZ was converted 
into its active metabolite 5-aminosalycilic acid.  
Martínez-Máñez  and co-workers reported thrombin-responsive 
MSNs, which were loaded with acenocoumarol (an anticoagulant 
drug) or safranin, and were capped with a specially designed 
peptide (LVPRGSGGLVPRGSGGLVPRGSK) that contained three 
repeats of the thrombin cleavage site.57 The peptide contained a 
pentinoic acid at one end, which was used to attach the sequence 
to the previously azide-functionalised silica surface via a copper(I)-
catalysed click reaction. In the presence of thrombin, the specific 
peptide was hydrolysed and resulted in cargo release. 
Acenocoumarol-loaded MSNs were proven to prolong the 
coagulation time of blood plasma in the presence of thrombin. 
Martínez-Máñez and co-workers prepared peptide-capped 
MSNs loaded with safranin for cargo delivery, triggered by caspase 
3 (C3).58 The peptide (KKGDEVDKKARDEVDK) contained two repeat 
units of a target sequence (DEVD), known to be hydrolysed by C3. 
MSNs were functionalised with 3-(azidopropyl) triethoxysilane, 
loaded with safranin and then the alkyne-containing peptide 
sequence was attached by a click reaction to the azide groups on 
the silica surface. In the absence of C3, the system showed minor 
release, whereas remarkable payload delivery was observed in the 
presence of the enzyme due to the hydrolysis of the peptide 
sequence. The prepared MSNs were internalised in HeLa cells by 
electroporation to avoid endocytosis by taking into account the 
cytoplasmatic location of C3. In order to induce C3, cells were 
treated with staurosporin (STS), which resulted in apoptosis with 
the consequent C3 activation in the cytosol. Safranin delivery in 
cells was observed only when C3 was activated. The sequence of a 
cell-penetrating peptide was added to the N-terminal end of the 
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capping peptide and was used to prepare an additional solid, which 
was able to internalise and deliver its payload in C3-activated HeLa 
cells without requiring electroporation. 
3.2. Hydrolysis of ester and phosphodiester groups 
Esterases have been extensively used as triggers by taking into 
account the fact that they are enzymes capable of hydrolysing the 
ubiquitous ester linkage. The first esterase-driven gated MSN was 
published by Stoddart and co-workers. These authors loaded MSNs 
with Rh B and the external surface was functionalised with PEG 
stalks that encircled α-CDs and finished with an ester-linked 
adamantly bulky stopper (see Figure 5A). In the presence of porcine 
liver esterase (PLE), the ester linkage was hydrolysed with the 
subsequent removal of adamantly stopper, which resulted in Rh B 
release.59,60 The same authors prepared a closely related system, 
but by loading MSNs with fluorescein or CPT, and then capping 
pores with the PEG stalks encircled with α-CDs, which ended with 
folic acid (FA) as a stopper (see Figure 5B). Once again, addition of 
PLE induced cargo release. The gated nanoparticles loaded with CPT 
were efficiently endocyted by human osteosarcoma U2Os cells and 
induced marked cell death, which was more marked than that 
obtained with the cells treated with the free drug.61  
 
Figure 5. PLE-induced controlled release of A) Rh B and B) CPT from 
the MSNs capped with and A) the ester-linked adamantyl stopper or 
B) with an ester-linked FA stopper. 
Some of us have reported a gated material composed of MSNs 
loaded with the Ru(bipy)32+ complex and capped with 
oligoethyleneglycol chains that contain an ester linkage. Water 
suspensions of nanoparticles at pH 8.0 showed negligible cargo 
release due to the presence of bulky oligoethyleneglycol chains 
around pore outlets. In the presence of esterase, marked dye 
delivery was observed due to ester linkage hydrolysis and the 
detachment of bulky oligoethyleneglycol chains.62 The esterase-
induced opening mechanism was corroborated because amidase, 
urease and denaturated esterase were unable to induce pore 
opening. Besides the nanoparticles loaded with CPT were 
internalised by HeLa cells, which triggered cell death due to the 
hydrolysis of capping ester-containing glycol chains in lysosomes 
and drug release. In another work, the same authors prepared 
MSNs loaded with Rh B, with the external surface functionalised 
with polyester polymers that contained side-chain azobenzene 
moieties.63 In the absence of the esterase enzyme, negligible dye 
release was observed, whereas a marked payload delivery took 
place in the presence of the enzyme. CPT-loaded capped 
nanoparticles induced cell death in HeLa cells. 
[2]Pseudorotaxanes derivatives were used as esterase-
hydrolysable caps by Yang and co-workers.64 For this purpose, the 
authors synthesised a carboxylic acid-choline derivative. This 
derivative was anchored to the silanol groups on the surface of 
MSNs through an esterification reaction. Then the functionalised 
material was loaded with Rh B and capped by the formation of 
[2]pseudorotaxanes between the grafted choline derivative and p-
sulfonato-calix[4]arene. The PBS suspensions of the capped 
nanoparticles showed negligible Rh B release in the absence of 
esterase, but remarkable cargo delivery in the presence of the 
enzyme. Cargo release was ascribed to the hydrolysis of the ester 
linkage that resulted in the dethreading of [2]pseudorotaxane from 
the surface. Addition of ethanediamine to suspensions of 
nanoparticles induced pore opening and Rh B delivery due to the 
competitive binding of this molecule with p-sulfonato-calix[4]arene.  
Polycaprolactone (PCL) was used as a capping agent to develop 
esterase-triggered nanodevices by Gooding and co-workers. These 
authors used pore-expanded MSNs as an inorganic support, which 
was loaded Rh B or DOX. Then PCL was also loaded and the external 
surface was functionalised with aminopropyl moieties. Finally, 
nanoparticles were coated with polyacrylic acid (PAA) through 
electrostatic interactions with anchored protonated amines.65 
Cargo release was observed only at pH 5.5 and in the presence of 
esterase. At an acidic pH, the PAA layer was detached from the 
external surface to allow esterase to access the interior of pores 
with subsequent PCL hydrolysis and entrapped cargo release. The 
nanoparticles loaded with Rh B were internalised by HeLa, 
neuroblastoma (SK-N-BE(2)) and fibroblast (MRC-5) cells, with no 
reported cytotoxic effect. An 8-fold toxicity increase in SK-N-BE(2) 
cells was observed when nanoparticles where loaded with DOX. 
PCL was also used by Zhou and co-workers to prepare esterase-
triggered nanodevices that used MSNs with carbon quantum dots 
embedded in the silica matrix. MSNs were reacted with 
functionalised 3-(trimethoxysilyl)propyl methacrylate to yield 
alkene moieties on the silica surface. Afterwards, cysteamine and 2-
(dimethylamino)ethanethiol (DME) were grafted on MSNs by 
thiolene “click chemistry”. Next, a further reaction of 2,3-
dimethylmaleic anhydride (DMA) with cysteamine yielded a 
zwitterionic surface (composed of oppositely-charged moieties; i.e. 
–COO– from DMA and –NH+(CH3)2 from DME). The anionic part was 
designed to be protonated at a pH below 6.8. Finally, pores were 
loaded with DOX and closed upon the addition of PCL, which was 
physisorbed in pore outlets via an impregnation process.66 At pH 
6.8, the zwitterionic surface became positive due to the 
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DOX release. In the presence of esterase at a pH higher than 6.8, no 
release was noted due to the repulsion between the zwitteronic 
layer and the enzyme. Besides, the PLE-capped nanoparticles had a 
strong cytotoxic effect on SCC cancer cells due to their higher 
extracellular acidity (pH < 6.8), whereas DOX release in HaCaT 
(normal cells) was negligible due to the repulsion between the 
zwitteronic layer and the enzyme at a pH above 6.8.  
The hydrolysis of phosphate esters has also been used as an 
opening mechanism in certain gated nanodevices. In these 
examples, acid phosphatase and DNAse I (which cleaves DNA 
preferentially at the phosphodiester linkages adjacent to a 
pyrimidine nucleotide) were used as triggers. In a first example, 
MSNs were loaded with Ru(bipy)32+ and the external surface was 
functionalised with a linear triamine. The capped material was 
obtained after adding ATP, which formed supramolecular 
complexes with the positively-charged amino moieties on the 
surface.67 In the absence of acid phosphatase, negligible dye release 
was observed. However in the presence of the enzyme, marked 
Ru(bipy)32+ delivery was seen due to ATP hydrolysis. These capped 
nanoparticles were mixed in a second step with gelatine and 
glutaraldehyde to construct a 3D scaffold in which acid 
phosphatase-triggered delivery was assessed. Studies carried out 
with the human osteoblast cell line HOS showed that the scaffold 
did not elicit any cytotoxic effect, and that cells adhered, 
proliferated and spread well in the scaffold. 
The first example of capped nanoparticles triggered by DNAse I 
was reported by Zhu and co-workers in 2011. These authors used 
hollow MSNs with pores loaded with fluorescein and the external 
surface functionalised with aminopropyl moieties.68 Pores were 
finally capped upon the addition of a negatively-charged cytosine-
phosphodiester-guanine oligodeoxynucleotide by a simple 
electrostatic interaction with the positively-charged protonated 
amino moieties onto the surface. In the absence of DNAse I, 
negligible fluorescein release was observed, whereas the cap was 
hydrolysed and cargo was delivered when it was present. Wu and 
co-workers followed a similar procedure and prepared MSNs 
loaded with colchicine and with the external surface also 
functionalised with aminopropyl groups. However in this case, the 
authors capped colchicine-loaded nanoparticles using several 
negatively-charged single-stranded DNAs of edible plants Solanum 
lycopersicum and Triticum aestivum.69 Once again, cargo release 
was observed in the presence of DNAse I due to the hydrolysis of 
capping DNAs. 
Willner and co-workers prepared four different functionalised 
MSNs with amino groups and linked DNA sequences by covalently 
using sulfo-EMCS.70 The first nanodevice was loaded with Rh B and 
capped with a DNA sequence (DNA-1) capable of forming a hairpin 
at room temperature to block pores. The gate contained a single 
sequence strand, which can be recognised by a nucleic acid 
biomarker (i.e. 5′-AGT GTG CAA GGG CAG TGA AGA CTT GAT TGT-
3′). When the biomarker was added to the suspension of 
nanoparticles, the hairpin opened and formed a duplex, but pores 
remained closed and no dye was released until the Exo III enzyme 
was added. This enzyme hydrolysed the 3′-end of the sequence and 
allowed the release of Rh B. Another sequence was grafted (DNA-2) 
and 5′-ATC CTC AGC TTC G-3′ was used as a biomarker. The formed 
DNA duplex was able to cap pores and to maintain the cargo inside 
pores. Enzyme Nb.BbvCl produced the duplex dissociation due to 
the specific cleavage of one base, and cargo was released. The third 
nanodevice was functionalised with DNA-3, and also with a hairpin 
structure, and an ATP-aptamer conjugated with a sequence 
hydrolysable by enzyme Exo III was incorporated. The hairpin open 
upon the addition of ATP and enzyme Exo III, which hydrolysed the 
3′ end of DNA-3. For the last material, DNA-4 was grafted onto the 
surface. DNA-4 contained an ATP-aptamer and a sequence 
hydrolysable by enzyme Nb.BbvCl. The authors used DNA-3 capped 
material loaded with CPT for the cellular uptake studies in MDA-
MB-231 (breast cancer cells) and MCF-10a (normal breast cells). 
After the endocytosis of nanoparticles, approximately 40% more 
cancer cells died compared with normal cells.  
3.3. Glycosidic linkages 
Glycosidases are present in almost all living organisms where 
they play diverse and different roles. Glycosidases catalyse the 
hydrolysis of glycosidic linkages by degrading oligosaccharides and 
glycoconjugates. The first example of a porous support gated with 
“saccharides” was published by Martínez-Máñez and co-workers.71 
Mesoporous silica microparticles were loaded with Ru(bipy)32+ and 
capped with the trialcoxysilane-lactose derivative. Suspensions of 
this material were stirred in both the presence and absence of β-ᴅ-
galactosidase enzyme, which induced progressive cargo release (see 
Figure 6A). In another work, the same authors used Glucidex 47, 
Gludicex 39 and Glucidex 29-trialkoxysilane derivatives (Glucidex is 
a hydrolysed starch) as molecular gates and Ru(bipy)32+ as the cargo 
in a mesoporous silica support.72 In the absence of pancreatin, 
cargo release was inhibited, while the hydrolysis of the glycosidic 
bonds and dye release occurred in the presence of this mix of 
amylase enzymes (see Figure 6B). HeLa and LLC-PK1 cells were 
incubated with Ru(bipy)32+-loaded Glucidex 47-capped 
nanoparticles to study cellular uptake by confocal microscopy. 
Nanoparticles were internalised by endocytosis, and concentrated 
in endosomes and lysosomes. Cytotoxicity assays revealed that 
capped MSNs were biocompatible. The same Glucidex 47-capped 
nanoparticles, but loaded with DOX, were clearly toxic for HeLa 
cells. The microparticles loaded with garlic extract and capped with 
Glucidex 47 were also prepared by the same authors.73 The capped 
material was embedded into a nylon-6 membrane and the release 
properties of the nanocomposite were tested in the presence of 
pancreatin, which hydrolysed starch and aimed cargo delivery.  
In 2012, the same research group prepared silica nanoparticles 
with Rh B as the cargo, capped with the galacto-oligosaccharide 
(GOS)-trialcoxysilane derivative.74 Suspensions of the capped 
nanoparticles showed negligible cargo release, whereas Rh B was 
delivered in the presence of β-galactosidase (see Figure 6C). 
Release experiments were performed in yeast cells, in which β-
galactosidase was found at normal concentrations or was 
overexpressed. Rh B only stained cells that overexpressed the 
enzyme because of the hydrolysis of the capping GOS and cargo 
release. The same experiment was carried out with X-linked 
Dyskeratosis congenita (X-DC) patient´s fibroblast (β-galactosidase 
was overexpressed) and in H460 cells (β-galactosidase was not 
overexpressed). In the former cell line, Rh B delivery was much 
more significant.  
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Qu and co-workers prepared Rh B-loaded MSNs capped with 
Konjac oligosaccharide (KOGC), a derivate of Konjac plants.75 The 
delivery behaviour of the solids capped with different quantities of 
KOGC in the presence of different enzymes was studied, and cargo 
delivery was observed only in the presence of β-mannanase, an 
enzyme secreted by bacteria that can hydrolyse KOGC (see Figure 
6D). Internalisation and biocompatibility studies were performed by 
incubating Caco-2 cells with Rh B-loaded KOGC-capped MSNs. 
Nanoparticles were endocytosed by cells and cell viability was not 
affected.  
Other polysaccharides have been used as molecular gates; e.g., 
Qu and co-workers loaded MSNs with Rh B, functionalised the 
external surface with APTES, and capped nanoparticles with 
hyaluronic acid (HA) using EDC (1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride) /N-
hydroxysuccinimide (NHS).76  Hyaluronidase (HAase) is an enzyme 
present in tumour environments that is capable of hydrolysing HA. 
Release experiments showed that the cargo was delivered only in 
the presence of HAase. Two cell lines, NIH3T3 and MDA-MB-231, 
were incubated with Rh B-loaded HA-capped MSNs, where 
internalisation was much higher in the MDA-MB-231 cells (which 
overexpress the CD44 receptor) and demonstrated the targeting 
effect of HA. The same nanoparticles loaded with DOX showed 
toxicity to MDA-MB-231 cells. 
 
Figure 6. Controlled cargo release from saccharide-capped MSNs 
triggered by the hydrolysis of glycosidic bonds. 
The same authors prepared up-converting nanoparticles 
(UCNPs, NaGdF4:Yb,Tm), firstly coated with a silica shell and then 
with mesoporous TiO2.77 The TiO2 shell pores were loaded with DOX 
and capped with HA by electrostatic interactions. Suspensions of 
capped nanoparticles in buffer at pH 4.3 showed only 17% of cargo 
release, whereas DOX release reached 95% in the presence of 
HAase. Both the NIH3T3 and MDA-MB-231 cell lines were incubated 
with capped nanoparticles, yet the emission intensity from 
NaGdF4:Yb,Tm was observed only in cancer MDA-MB-231 cells (due 
to the interaction of HA with the overexpressed CD44 receptor on 
the membrane of these cells). These authors aimed to use gated 
nanoparticles in photodynamic therapy. For this purpose, they 
irradiated the NaGdF4:Yb,Tm core with 980 nm light by inducing an 
energy transfer process, which activates TiO2 to produce ROS. The 
nanoparticles activated with NIR light caused more cellular death 
than with only the effect of DOX released from the nanodevice. This 
fact was ascribed to the combination of both NIR light and HAase 
stimuli, which simultaneously induced ROS generation and DOX 
release.  
Another example of HA-capped material was described by the 
same authors. They loaded DOX in gold nanocrystals (AuNCs) of 50 
nm that contained pores between 5 nm and 8 nm, and capped 
them with dopamine-derivatised HA.78 HA was functionalised with 
dopamine (DA) by a condensation reaction using EDC/NHS. The 
amino groups in DA-HA interacted with the surface of AuNCs and 
capped pores. DOX delivery was induced by HAase and improved 
with NIR light. The same above-mentioned assays with MDA-MB-
231 cells were performed, and the authors demonstrated the 
nanodevice’s effectiveness. Nanoparticles were internalised by 
MDA-MB-231 cells through HA-CD44 interactions, and the 
cumulative effect of released DOX and NIR irradiation reduced cell 
viability to only 18%. Besides, nude mice xenografted with MDA-
MB-231 cells were treated intratumourally with both DOX-loaded 
HA-capped AuNCs and NIR irradiation, which induced subsequent 
tumour ablation. 
Wang and co-workers prepared a mesoporous silica-based 
system that was sensitive to both redox and enzyme stimuli, and 
capable of targeting receptor CD44 in cells.79 MSNs were 
functionalised with (3-mercaptopropyl) trimethoxysilane and pores 
were loaded with DOX. The thiol groups on the surface were 
conjugated with S-(2-aminoethylthio)-2-thiopyridine. Finally, pores 
were capped with HA through the formation of amide bonds. The 
kinetics studies carried out with HA-capped MSNs revealed that 
when nanoparticles were suspended in PBS at pH 5.0 in the 
presence of GSH and HAase, 60% DOX was released. However when 
both stimuli were absent, only 20% of DOX was delivered. The 
authors studied the internalisation of HA-capped MSNs in HCT-116 
(which overexpress the CD44 receptor) and NIH-3T3 (as a negative 
control) cells. HA-capped MSNs were more efficiently uptaken by 
HCT-116 than by NIH-3T3 cells. Cytotoxicity assays revealed that the 
IC50 of HA-capped MSNs for HCT-116 cells was 0.6 µg mL-1, but was 
4.5 µg mL-1 for NIH-3T3.  
Qu and co-workers prepared Fe3O4 magnetic nanoparticles 
coated with a mesoporous silica shell and loaded with DOX or 
chlorambucil (Chl). HA was functionalised with double bonds by 
reacting HA with methacrylic anhydride to obtain a methacrylated 
hyaluronic acid (m-HA) polymer. The external silica surface was 
functionalised with APTES and covered (through electrostatic 
interactions) with m-HA.80 Drug release studies were carried out by 
suspending nanoparticles in PBS buffer solution at pH 7.4 without 
HAase to simulate normal tissue, or in PBS solution at pH 5.0 with 
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suspension at pH 7.4 in the absence of HAase showed negligible 
DOX release (less than 10% after 24 h), but marked release was 
observed (50% after 24 h) at pH 5.0 and in the presence of the 
enzyme. Chl released from nanoparticles reached 30% (after 24 h) 
at pH 7.4 in the absence of HAase, whereas the release was 100% 
after 24 h at pH 5.0 and in the presence of the enzyme. Cellular 
uptake and delivery studies in the HeLa and MDA-MB-231 cell lines 
were carried out with the prepared materials. Cytotoxicity studies 
in cancer cells (HeLa and MDA-MB-23) and in normal cells (L02 
human hepatocytes and HUVEC) indicated that coated 
nanoparticles showed weak toxicity to normal cells, but strong 
toxicity to tumour cells. 
Chen and Liu prepared fluorescein-labelled MSNs capped with 
HA and capable of entrapped cargo release in the presence of 
HAase.81 MSNs were functionalised with APTES and nanoparticles 
were further labelled by reacting fluorescein isothiocyanate with 
the amino groups on the silica surface. Nanoparticles were loaded 
with DOX and finally capped with HA via electrostatic interactions 
between the carboxylic groups in HA and the protonated amines on 
the surface of MSNs. At a slightly acidic pH (6.8), which simulated 
fluid in tumour tissue, capped MSNs formed hydrogels of ca. 10,000 
nm due to the hydrogen bond interactions between the carboxyl 
groups from HA from several nanoparticles. Cargo release from 
hydrogels at pH 6.8 was studied in the absence and presence of 
HAase. No release occurred in the absence of the enzyme, but 
remarkable cargo delivery was observed due to the hydrolysis of HA 
in the presence of HAase. Nanoparticles were tested in both human 
breast cancer cells (SKBR3) and human embryonic kindness cells 
(293T). DOX was delivered preferentially in cancer cells due to the 
presence HAase and the high expression of CD44 antigen, which is a 
receptor for HA.  
Chitosan has also been used as molecular gates to design 
enzyme-responsive capped materials. For example, Lou and co-
workers functionalised mesoporous silica with APTES and made it 
react with succinic anhydride. The material was loaded with Rh B or 
DOX, and capped with chitosan by amide formation using 
EDC/NHS.82 Cargo release was observed either in the presence of 
lysozyme at pH 7 or by changes in pH, particularly at pH 4.  
Kim and co-workers reported α-amylase and lipase-responsive 
MSNs, which were capped with β-CDs and loaded with calcein.83 
MSNs were functionalised with APTES, which were later reacted 
with propargyl bromide to yield alkyne groups on the silica surface. 
Then nanoparticles were loaded with calcein and capped with 
mono-6-azido-β-CDs by a click chemistry reaction. A second solid 
was capped using β-CDs linked to the silica through an o-nitrobenzyl 
ester moiety on the stalk part. For this second solid, firstly an o-
nitrobenzyl ester derivative was linked to amino-functionalised 
MSNs by an amide bond and then mono-6-azido-β-CD was attached 
to the ester by a click reaction. Both solids showed remarkable 
cargo release in the presence of α-amylase due to the hydrolysis of 
β-CD. The solid that contained o-nitrobenzyl ester moiety was able 
to deliver the cargo in the presence of lipase. When both α-amylase 
and UV were used as stimuli, calcein release from the second solid 
accelerated since o-nitrobenzyl ester is a photocleavable linker. 
By employing pancreatin enzyme as a stimulus, Martínez-Máñez 
and co-workers developed the first example of a family of gated 
nanoparticles that communicate by exchanging chemical 
messengers.84 The communicating system consisted of three 
different solids. In the presence of pancreatin, the first solid 
delivered a chemical messenger, which was able to open the 
second type of nanoparticles. This delivered another messenger 
that opened a third gated material. The first solid was loaded with 
reducer tris(2-carboxyethyl)phosphine (TCEP) and was capped with 
a galacto-oligosaccharide (GOS)-trialcoxysilane derivative, as in 
Reference 74. The second MSNs were loaded with 
dodecyltrimethylammonium bromide (DTAB) and capped with a 
PEG linked to the silica surface through disulphide bonds (sensitive 
to TCEP). Finally for the third solid, MSNs were loaded with 
safranin-O and capped with a lipid bilayer (prepared from 1,2-
dioleoyl-sn-glycero-3-phosphocholine, DOPC), which was disrupted 
in the presence of DTAB. 
Lou, Xia and co-workers prepared DOX-loaded MSNs capped 
with cellulose for controlled drug delivery triggered by enzyme 
cellulase glycosidase and pH.85 The external surface of MSNs were 
functionalised with carboxylic groups and pores were loaded with 
DOX. Cellulose was attached to nanoparticles through ester linkages 
between the COOH groups on the silica surface and the OH groups 
in the biopolymer. Negligible release was observed at pH 7.4, yet 
DOX delivery increased at an acidic pH due to the hydrolysis of ester 
linkages and the uncapping of pores. Pore opening and DOX 
delivery were observed in the presence of cellulose glycosidase at 
pH 7.4 due to the rupture of the glycoside bonds of the biopolymer. 
The authors prepared the same nanoparticles labelled with 
fluorescein, which were successfully tested for intracellular DOX 
delivery in HepG2 tumour cells. 
3.4. Rupture of azo bonds 
Reductases are enzymes present in intestinal microflora and 
capable of reducing azo bonds. Martínez-Máñez and co-workers 
prepared MSNs loaded with Rh B or CPT, and capped with a bulky 
azopyridine derivative (Figure 7A).86 The authors demonstrated that 
cargo delivery from gated-MSNs only occurred in the presence of 
reductase or esterase enzymes, whereas the nanodevice remained 
capped with pepsin (an enzyme present in stomach). The authors 
suggested that nanoparticles could be used as a specific drug 
delivery system in colonic diseases. Moreover, HeLa cells treated 
with CPT-loaded nanoparticles underwent apoptosis due to 
nanoparticle internalisation and pore opening.  
With a similar approach, Sun and co-workers loaded MSNs with 
IBU and functionalised the external surface with APTES. The 
reaction between the amino groups on the surface of nanoparticles 
and azobenzene-4,4′-dicarboxylic acid yielded the final capped 
system.87 Negligible IBU release took place when capped 
nanoparticles were suspended in simulated gastric fluid (SGF) for 1 
h or in simulated intestinal fluid (SIF) for 4 h (see Figure 7B). 
However when capped nanoparticles were suspended in simulated 
colonic fluid (SCF), IBU release rose to more than 83%. This marked 
IBU release was ascribed to the hydrolysis of the azo bond by 
reductases and subsequent pore opening. 
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Figure 7. Reductase-induced controlled cargo release from MSNs 
functionalised with azo derivatives. 
3.5. Telomerase 
Telomerase is a reverse transcriptase enzyme that carries its 
own RNA molecule (with sequence "CCC AAU CCC" in vertebrates), 
which is used as a template when it elongates telomeres. In the 
examples reported below, telomerase was used to extend DNA 
sequences.  
Ju and co-workers prepared a nanodevice for the sensitive 
detection of telomerase activity in order to distinguish normal cells 
from cancer cells.88 These authors anchored a fluorescent quencher 
to the inner pore surfaces in MSNs and further loaded pores with 
fluorescein. Then the external surface of MSNs was functionalised 
with APTES and capped with a DNA sequence via electrostatic 
interactions, capable of activating telomerase (see Figure 8). This 
oligonucleotide sequence was extended in the presence of 
telomerase and deoxy-nucleoside triphosphate (dNTPs). When the 
DNA sequence was long enough, it formed a rigid hairpin and 
detached from MSNs, which resulted in fluorescein release. These 
MSNs were used for tracking intracellular telomerase activity in 
HeLa cells. In order to demonstrate telomerase responsive 
behaviour, HeLa cells were treated with different telomerase 
inhibitors (telomerase sense oligodeoxynucleotide, telomerase 
antisense oligodeoxynucleotide and epigallocatechingallate) and no 
cargo release was observed. Finally, the prepared nanoparticles 
were able to distinguish QSG-7701 liver cancer cells from BEL-7402 
liver cells. 
 
Figure 8. Telomerase-induced controlled fluorescein release from 
ssDNA-capped MSNs functionalised with a fluorescence quencher in 
the interior of pore walls.  
Similarly, Lu and co-workers prepared a capped material to 
study telomerase activity with a glucometer. In this case, MSNs 
were loaded with glucose, functionalised with 3-
(aminopropyl)trimethoxysilane and then capped with a single 
stranded DNA sequence through electrostatic interactions.89 The 
glucometer signal showed linear dependence within the range of 
100 to 5000 HeLa cells. The limit of detection was 80 HeLa cells mL-
1. In another paper, Cui and co-workers used a similar approach, but 
selected Au@Ag nanorods coated with a mesoporous silica shell as 
the inorganic support.90 Mesoporous layer pores were loaded with 
DOX, and were then capped upon addition of a single DNA strand 
that contained a telomeric repeat complementary sequence and a 
telomerase substrate primer sequence. In the presence of 
telomerase, pores were uncapped and DOX was released. The 
authors were able to follow the uptake of the capped nanodevice in 
HeLa cells using SERS. 
3.6. Miscellaneous 
Huo and co-workers prepared MSNs functionalised with 
ferrocene moieties, which were sensitive to the redox changes 
induced by the presence of enzymes or by applying a voltage.91 
MCM-41 MSNs were prepared and their external surface was 
functionalised with APTES. In a second step, a ferrocene derivative 
that contained a carboxylic acid moiety was grafted onto the 
external surface by the formation of amide bonds. Finally, pores 
were loaded with Rh B and capped upon the addition of β-CDs 
(which formed inclusion complexes with grafted ferrocenes). The 
application of a +1.5V pulse oxidised ferrocene with the 
dethreading of the inclusion complex and subsequent cargo 
delivery. The combination of glucose, glucose oxidase (GOD) and 
horseradish peroxidase (HRP) also induced ferrocene oxidation and 
pore opening. 
Wu and co-workers prepared NAD(P)H:quinone oxidoreductase 
1 (NQO1)-responsive MSNs gated with a rotaxane nanovalve and 
loaded with Rh B or DOX.92 Rotaxane was formed by coordinating α-
CDs with a diethylene glycol stalk anchored to the surface of MSNs 
with a benzoquinone stopper. Enzyme NQO1 induced the reduction 
of benzoquinone with the subsequent stopper cleavage, which 
allowed a payload delivery. Delivery from DOX-loaded nanoparticles 
in cells with (i) high NQO1 expression (A549 and MCF-7 cells) and 
(ii) cells that lack enzyme NQO1 (HL-60 cells) was studied. Although 






































5´-(CCCTAA)nAAT CCG TCG AGC AGA GTT-3´
Telomerase primer
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 13  
Please do not adjust margins 
Please do not adjust margins 
observed only in the cells with a high NQO1 expression. The DOX-
loaded system was demonstrated to inhibit tumour growth in mice. 
Conclusions 
We have herein reviewed the use of porous supports for 
controlled delivery applications based on employing enzymes. 
Enzyme-triggered gated materials are expected to offer remarkable 
applications in the biomedical field. So although there are a 
relatively large number of examples that use esterases, 
glycosidases, peptidases, reductases and DNases, this subfield in 
gated chemistry area has not yet been fully explored. Further 
advances will most likely take into account that the flow of certain 
biological processes relies on complex biochemical networks, along 
with the participation of multiple enzyme-dependent steps. Enzyme 
overexpression in certain diseases can be used to design 
personalised capped materials to be opened in a specific cell type 
and thus reduce undesirable side effects and increase the 
effectiveness of the delivered drug. Finally, the fact that synthetic 
molecules can be designed to contain both fragments recognised by 
target-enzymes and moieties for targeting certain cells, or for cell 
entry-control, also suggests that there is still plenty of room in this 
research area. Yet despite the exponential development of this 
field, drawbacks still need to be overcome. For instance, it must be 
recognised that in most published studies, delivered molecules are 
dyes/fluorophores used in an attempt to demonstrate the working 
mechanism of the gated ensemble, and fewer examples have been 
designed for real applications. Moreover, the potential 
bioaccumulation of MSNs or other porous supports when used in 
vivo is a subject that must be addressed, and more studies in this 
field must be carried out. By bearing all this in mind, new advances 
in the gated nanochemistry field using enzymes are anticipated in 
the near future. 
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